Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Aura Biosciences, Inc. (NASDAQ: AURA) is capturing the attention of investors with its promise of significant upside potential. With a 247.54% potential upside based on analyst ratings, this Boston-based biotechnology..
In the dynamic world of biotechnology, Candel Therapeutics, Inc. (NASDAQ: CADL) is capturing investor attention with its promising potential upside of 306.34% as per analyst ratings. As a clinical stage..
ClearPoint Neuro Inc. (NASDAQ: CLPT) is a compelling player in the healthcare sector, specifically within the medical devices industry. Operating primarily in the United States, ClearPoint Neuro is making waves..
Spok Holdings, Inc. (NASDAQ: SPOK), a key player in the healthcare communication solutions sector, offers an intriguing investment opportunity with its current market dynamics. With a market capitalization of $359.72..
UroGen Pharma Ltd. (NASDAQ: URGN), a prominent player in the biotechnology industry, has recently captured investor attention with its substantial potential upside and promising pipeline of cancer treatment solutions. As..
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA), a trailblazing entity in the biotechnology sector, is gaining significant attention within the investment community for its promising pipeline and impressive potential upside. As a..
Erasca, Inc. (NASDAQ: ERAS), a clinical-stage precision oncology company, is capturing attention with its potential upside of 173.74% according to the latest analyst estimates. Specializing in therapies for RAS/MAPK pathway-driven..
TruBridge, Inc. (TBRG), a stalwart in the Health Information Services industry, is attracting attention with its promising potential upside of 18.82%. With a market cap of $312.69 million, this healthcare..
Absci Corporation (NASDAQ: ABSI), a pioneering entity in the biotechnology sector, is capturing investor attention with its innovative approach to drug creation and a compelling potential upside of 218.71%. With..
Kamada Ltd. (NASDAQ: KMDA), an Israeli healthcare company specializing in plasma-derived protein therapeutics, has emerged as an intriguing prospect for investors in the drug manufacturing sector, especially given its impressive..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) has captured the attention of investors with its ambitious strides in the biotechnology sector. With a market capitalization of $1.05 billion, this clinical-stage biopharmaceutical company..
Individual investors seeking opportunities in the healthcare sector, particularly in regenerative medicine, may find Organogenesis Holdings Inc. (NASDAQ: ORGO) an intriguing prospect. This Massachusetts-based company specializes in developing, manufacturing, and..
AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector, specializes in the design and manufacturing of advanced medical, surgical, and diagnostic devices. With a focus on treating peripheral..
Treace Medical Concepts, Inc. (NASDAQ: TMCI), a key player in the healthcare sector specializing in medical devices, is drawing attention with its innovative solutions for bunion and midfoot deformities. Founded..
In the ever-evolving landscape of biotechnology, Precigen, Inc. (NASDAQ: PGEN) has emerged as a notable player, captivating investor interest with its innovative approach to gene and cell therapies. As a..
Myriad Genetics, Inc. (NASDAQ: MYGN) operates at the intersection of molecular diagnostics and precision medicine, offering an extensive array of genetic testing services. Despite its innovative portfolio, Myriad’s financial performance..
Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, stands at a fascinating juncture with a compelling potential upside of 366.12%. As a player in the biotechnology sector, Altimmune focuses on..
Sonida Senior Living, Inc. (NASDAQ: SNDA), a prominent player in the healthcare sector, operates senior housing communities across the United States. With a market capitalization of $490.34 million, the company..
Prothena Corporation plc (NASDAQ: PRTA) is carving a niche for itself in the biotechnology sector with a focus on innovative therapies for diseases caused by protein dysregulation. Based in Dublin,..
